INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

82,103 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$383K
9,258 sh
Jan 15, 2026Jan 16, 2026
Page 1708 of 2053
← PrevNext →
traded Jan 15, 2026
+1d
SEC Form 4

Evidence

4
RW
Ruttenberg David W.Director
ACELAccel Entertainment, Inc.
Open-market sale · 10b5-1 plan
SELL$145K
12.5K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$448K
10.7K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$479K
11.5K sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

4
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$348K
8,467 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

3
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M—
2,813 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

3
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Grant or award · 10b5-1 plan
A—
37.2K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

2
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M$93K
5,893 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

2
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$68K
14.6K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

1
PA
Peer AndrewVP, Corporate Controller & CAO
ACVAACV Auctions Inc.
Open-market sale · 10b5-1 plan
SELL$15K
1,750 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
PA
Peer AndrewVP, Corporate Controller & CAO
ACVAACV Auctions Inc.
Option exercise · 10b5-1 plan
M$4,270
1,750 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
62.5K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M—
2,678 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
62.5K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
IR
Inukonda RaviCHIEF FINANCIAL OFFICER
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M—
1,017 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
PA
Peer AndrewVP, Corporate Controller & CAO
ACVAACV Auctions Inc.
Option exercise · 10b5-1 plan
M—
1,750 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M$94K
2,678 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
27.1K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
IR
Inukonda RaviCHIEF FINANCIAL OFFICER
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M$7,790
1,017 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
GD
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
BDXBECTON DICKINSON & CO
Option exercise · 10b5-1 plan
M—
3,054 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
250.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
DA
D'Amico AndrewDirector
VICRVICOR CORP
Option exercise · 10b5-1 plan
M$20K
200 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M$25K
1,407 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Grant or award · 10b5-1 plan
A—
44.7K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M—
1,407 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Option exercise · 10b5-1 plan
M—
5,000 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

0
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
5,000 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M$28K
2,813 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Grant or award · 10b5-1 plan
A—
300.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C—
250.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Option exercise · 10b5-1 plan
M—
5,000 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
27.1K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M$2,446
321 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Option exercise · 10b5-1 plan
M—
5,893 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

0
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
5,000 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
14.6K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

56
VW
Versaci Vincent WTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$11K
1,336 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

56
MJ
McNally Kevin JosephTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$5,135
634 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence